and B. The same was true also when PMN were co-stimulated with FMLP ( Fig. lC and D) . Thus, the ultimate effect of carnitine on a given PMN preparation was essentially the same irrespective of whether PMN had been primed by FMLP (Fig. 1A and C, and Fig. 1B and D ).
ROS production: Carnitine interfered with ROS production in all subjects (n 10) and its activity was fairly consistent in each individual, irrespective of the presence of PMA (Fig. 2) . To the authors' knowledge, this is the first demonstration of the capacity of carnitine to consistently influence the production of cytokines after endothelial damage, 11 it is possible to speculate that carnitine may represent a useful agent for PMN regulation.
